Trial intelligence / Profile preview

Ondansetron and Dexamethasone for Radiation-Induced Emesis

NCT00016380Phase 3Completed

Sponsor
Canadian Cancer Trials Group
Start
Feb 2001
Primary completion
Apr 2004
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of dexamethasone in radiation-induced nausea and vomiting (RINV), sponsored by Canadian Cancer Trials Group. Started Feb 2001; status: completed.

02

Drugs

dexamethasone
03

Conditions

radiation-induced nausea and vomiting (RINV)

Beyond the preview

Go deeper on NCT00016380.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00016380.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call